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De acordo com o capítulo “Tarefas a Realizar”, do Guia do Curso de Mestrado 
em Comunicação Clínica, a matéria da dissertação para a obtenção do grau de 
Mestre consta da realização de um trabalho de investigação com submissão a 
uma revista científica.  
 
Na presente dissertação é apresentado o trabalho de investigação realizado sob 
a forma de artigo científico. 
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ARTIGO DE INVESTIGAÇÃO 
 
Abstract  
Objective: Shared-Decision Making (SDM) has shown to improve compliance 
with the therapeutic plan, decrease hospitalization, and enhance the knowledge 
on the illness and satisfaction with mental health services. We aimed to unveil 
the perspective of both psychiatrists and patients diagnosed with depression on 
decision making.  
Methods: A convenience sample of physicians and patients with depression was 
recruited at the outpatient unit of a psychiatric hospital and submitted to a battery 
of self-report questionnaires. Standardized instruments were used to measure 
decision-making preferences and behaviors, and therapeutic alliance. The study 
was approved by the Ethical Committee. 
Results: Patients with depression prefer a model of decision making where their 
input is taken into account, but ultimately the decisions are relied to the 
psychiatrist. However, they experience a more participative role, with high levels 
of SDM behaviors. Therapeutic alliance did not vary according to patients’ 
sociodemographic characteristics. Severity of illness was negatively correlated 
with SDM behaviors and patient-physician relationship establishment.  
Conclusion: Depressed patients welcome SDM, and participate in the decisional 
process. This translates into better therapeutic alliance. Further studies should 
address the impact in other outcome variables, and unveil barriers and facilitators 
for SDM in this particular population. 
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1. Introduction 
People with mental illnesses are interested in being involved in the management 
of their conditions [1-3]. Patients consistently report positive attitudes towards 
shared-decision making (SDM) [4-6], with levels of interest higher than those 
experienced [2, 7-9]. Patients prefer a collaborative approach [10], rather than an 
informative or paternalistic one, but these preferences appear to vary in relation 
to the type of decision being made. Patients prefer to assume a collaborative role 
when facing psychiatric medications, an autonomous role for decisions related to 
psychosocial interventions, and a passive role with their primary care provider [8, 
11]. Psychiatrists, on the other hand consider psychosocial and lifestyle issues to 
be more suitable for shared decision-making than medical or legal decisions [12].  
Share Decision Model (SDM) is now being practiced at the level of information 
exchange in both psychiatric and primary care setting [13]. Observational studies 
found that the majority of professionals do not objectively favor involving the 
patient in the decision-making process [14-18]. Physicians report higher levels of 
patient’s participation than those experienced by the patient, who state minimum 
meaningful input into major decisions, especially about medications [7, 17, 19, 
20]. Taking into account patient preferences in treatment planning and delivery 
has been associated with several positive outcomes [19, 21], namely greater 
knowledge, satisfaction with treatment, feelings of being helped, involvement and 
activation of decision-making and improvement of treatment adherence with 
lower need for re-hospitalization [22-24]. There is a tendency to consider the 
shared approach to decision making as beneficial regarding commitment to 
therapy [25, 26], but no clear effects on clinical outcomes have yet been found 
[25, 27-30]. Higher quality of the clinical relationship has been associated with 
the capacity of involving patients in decisions, and clinicians involvement and 
alliance as shown to be responsive to enhanced shared decision-making[31]. 
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Therapeutic relationship is an independent predictor of treatment outcome, a 
mediating factor that captures significant variance in the outcome of treatment 
interventions such as pharmacological therapies, and an outcome per se [32]. 
Psychiatric patients who formed good therapeutic alliances with their therapists 
were found to be significantly more likely to remain in therapy, comply with the 
prescribed medication regimens, and achieve better outcomes with less 
medication [33].  
Physician may accept a collaborative approach to decision making in depression 
because patient’s involvement may be therapeutic itself, facilitates engagement 
and responsibility. [20]: Patients perceive a collaborative approach to decision 
making when physicians consider their opinion, talk with them about different 
treatment options and mutually agree on a decision [34]. Generally, according to 
observational studies, physicians tend to focus on the problem definition stage, 
failing to offer to the patient a variety of treatment options [18]. Involvement in 
therapeutic decisions has positive effects regarding treatment acceptance [35], 
adherence [36], clinical outcomes [37] and satisfaction with treatment [38, 39]. It 
is also claimed that SDM may directly alleviate key depressive symptoms, such 
as helplessness and hopelessness, indirectly improving clinical [40]. When 
considering uniquely the patient treatment preference component of SDM, a 
positive influence has been detected in treatment initiation [41] and adherence, 
but not in clinical outcomes [29, 41-45].  
Implementing SDM in psychiatric settings presents several difficulties. Disease 
dependent factors, fragmented services, prejudice, discrimination and the fear of 
coercive consequences can challenge psychiatric patient’s ability to actively and 
fully engage in shared decision-making [19]. Preferences for involvement vary in 
different patients and within patients over time [46], especially regarding 
antidepressant therapy. Patients with depression have frequently limited 
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knowledge on the availability and efficacy of psychiatric treatments [35, 47, 48]. 
Preference for counseling therapies [29, 35, 43, 49-54] or psychotherapy [41, 55-
64] is high, compared to medication. In clinical settings however most patients 
receive medication, meaning that less than 50% receive the therapy they prefer 
[35, 58].  
This study aims to unveil the perspectives, and preference on decision-making 
occurring in the clinical encounter with patients with depression and their 
assistant psychiatrists, furthermore measuring its association with the perceived 
quality of the clinical relationship.  
2. Material and Methods 
2.1. Population sample 
The study used a convenience sample of patients previously diagnosed with 
Depressive Disorder by experienced clinicians, working at a state mental health 
hospital. Inclusion criteria encompass the presence of depressive syndrome as 
assessed by the assistant psychiatrists. Patients were excluded when 
presenting other major psychiatric disorders, when unable to fulfill self-report 
questionnaire, or when the severity of the depressive illness encompassed 
hospital admission. 
A group of psychiatrists was invited to participate in the study using a “snow ball” 
criteria. All who voluntarily agreed to participate were included in the study.   
Patients and psychiatrists received written and verbal information about the 
study and signed an informed consent form. All the information was anonymized 
and coded for insuring the privacy of the data collected.  
2.2. Instruments 
8 
 
A battery of questionnaires permitted to evaluate sociodemographic 
characteristics and decision making experience and preferences. An original 
questionnaire, with a patient and physician versions was built for the present 
study to assess age, gender, education, and professional characteristics. In the 
patients form additional questions were included addressing: the onset of the 
psychiatric treatment, treatment changes in the present consultation and the 
perception of a decision process. Standardized measures included: 
2.2.1. Control Preference Scale (CPS): Originally developed to assess 
decisional preferences in women with breast cancer[65], it has 
also been used in various clinical contexts. The scale measures 
patient’s preferred decisional role using a five-point scale, with an 
agreement (Kendall’s tau-b) between self- and researcher-rated 
score of 0.82[66] and a moderate Test-retest reliability of 0.65[67]. 
The scores are then converted to a 0-10 scale (0 corresponding 
to an Informed Model of Decision Making, 5 to a Shared-Decision 
Making Model, and 10 to a Paternalistic Model). The original scale 
was further developed by Janz and collaborators[68] in order to 
include two additional parallel versions to assess for patient-
physician concordance – Patient Perception and Physician 
Perception. 
2.2.2. Shared Decision-Making Questionnaire (SDM-9-Q and SDM-Doc-
Q). This questionnaire is a brief self-report instrument for 
measuring shared decision-making in clinical encounters. Two 
translated versions of the scale were used: patient (SDM-9-Q)[69] 
and physician (SDM-Doc-Q)[70]. Both questionnaires showed 
good psychometric properties with a Cronbach's alphas of 0,938 
and 0,88 respectively. For the present study three additional items 
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were included to measure for: self-efficacy “My physician and I 
discussed the difficulties I might have in following with treatment”; 
professional disclosure – “My physician gave me his/her opinion 
on the best treatment for me”; and follow-up plan – “My physician 
and I planned for a follow-up contact”; found to be essential steps 
on the shared decision process[71]. Scores were converted to a 
0-100 scale [70]. Higher scores represent higher shared decision 
making. 
2.2.3. Agnew Relationship Measure – 12 item (ARM-12): This measure 
assesses the development of a therapeutic alliance between 
patient and physician[72], and was used as an outcome measure 
of shared decision-making. The authors used an adapted version 
of the ARM-12, found to have good levels of internal consistency 
and reliability (Cronbach's alpha coefficients of 0,68-0,83)[73]. 
The maxium score possible is 100, representing the highest 
quality clincal relationship.  
2.2.4. Hospital Anxiety and Depression Scale (HADS): This scale was 
used to measure the severity of depression[74]. It is composed of 
two 7-item subscales for measuring the presence of anxiety and 
depressive symptoms. It is widely used in primary care and 
psychiatric settings. The authors used the Portuguese version of 
the scale, translated and validated and presenting similar 
psychometric properties to the original version[75], with a 
Cronbach's alpha coefficients of 0.94. A score ranging from 8 to 
10 is considered mild, from 11 to 14 moderate and 15 to 21 
severe[76]. 
 
10 
 
2.3. Clinical assessment 
Clinical variables were surveyed regarding the presence of depressive 
symptoms, length of psychiatric treatment, and changes in therapeutic 
approaches. 
2.4. Data collection and analysis 
Patient’s recruitment and assessment was made immediately after the 
psychiatric consultation at an outpatient unit of a psychiatric hospital. The 
assistant psychiatrists were informed of the study beforehand and proposed to 
the patient to participate in the study at the closure of the consult. Once accepted, 
the researcher further informed the patient in a separate room of the study aims 
and procedures and all who accepted to participate signed an inform consent 
form and invited to fulfil the self-report questionnaires.  
A convenience sample of psychiatrists working in the same unit was collected 
and submitted to the professional’s questionnaires. 
Statistical analysis were performed using IBM® SPSS® Statistics v2.2. Descriptive 
statistics were used, for all the variables including Unidirectional ANOVA analysis 
in the patients’ sample, and T-student tests when regarding the professionals’ 
sample. Correlational analysis were performed with Pearson Correlation Test. 
  
2.5. Ethical considerations 
The study was submitted and approved by the Ethical Committee of Hospital de 
Magalhães Lemos, E.P.E; document number 1/2016 according to the 
Declaration of Helsinki. 
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3. RESULTS  
3.1. Participants sociodemographic and professional characterization 
The patient’s sample comprised 36 subjects, 68% (n=27) female, with a mean 
age of 39.8 (13.4) years. The educational achievement was in mean 11.4 (4.8) 
years. The majority of the sample were in psychiatric treatment for more than a 
year and 38.9% attended the first consultation. Ninety-two percent (n=33) were 
aware of a decision making process, with changes in medications reported in 
83.3% (n=30) of cases.  
The professional’s population assessed included 11 participants, 45.5% (n=6) 
female, with a mean age of 28.6 years (2.5). Nine were trainees and the sample 
presented a mean professional experience of 3.5 years (2.2). The reported mean 
consultation length was 29.9 minutes mean (5.8). Patients and psychiatrists 
sociodemographic and professional characterization is detailed in Table 1 and 2.  
Table 1: Patient’s sample characterization 
    n Percent 
N 36   
Age (years) 0-20  1 2.8% 
20-40  14 38.9% 
40-60  15 41.7% 
60-80  4 11.1% 
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Gender Female 27 75.0% 
Male 9 25.0% 
Education (years) <4 3 8.3% 
5-6 6 16.7% 
7-9 8 22.2% 
10-12  5 13.9% 
>13 13 36.1% 
Onset of psychiatric 
treatment (years) 
<1 13 36.1% 
1-10 12 33.3% 
>10 8 22.2% 
First contact with physician 14 38.9% 
Awareness of decision-making 
process 
33 91.7% 
Decisions on treatment Start  7 19.4% 
Mantain  6 16.7% 
Change  16 44.4% 
Terminate  7 19.4% 
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Table 2: Professional’s sample characterization 
    
 
 
N 11  
Age (years) 28.5 (2.5)  
Gender Female 5 
(45.4%) 
 
Male 6 
(54,5%) 
 
Experience (years) 3.5 (2.2)  
Length of consultation (min) 29.1 (5.8)  
Weekly hours of practice 40.0 (0.0)  
Consultations/day 9.8 (5.2)  
3.2.  Clinical evaluation 
Sixty-one percent (n=22) of the studied patients presented HADS scores 
compatible with moderate to severe scores, with an average score of 20.9 
(9,6). Patients with most severe depression (HADS total > 28) were 
significantly older (p=.016) and less educated (p=.004) (data not shown). 
(Table 3)   
Table 3: Clinical characterization  
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3.3. Patients’ and professionals perceptions on decision-making  
Control Preference Scale (CPS) scores revealed that patients perceived their 
doctor “made the final decision about which treatment would be used but 
seriously considered my opinion” in accordance to a mean score of 6.5 (2.1). The 
physician’s score in the CPS showed a value of 6.8 (2.3). No differences were 
found regarding age, gender or education level. 
Shared Decision-Making Questionnaire (SDM-9-Q) showed a mean score of 77.2 
(19.7) reflecting patients perception of a shared decisional process. The patients 
with most severe disease (HADS>28) reported significantly less SDM behaviors 
(p<.001). The questions with higher scores were “My doctor and I planned for a 
follow up contact”; “My doctor and I discussed the difficulties I might have in 
following treatment” and “My doctor helped me understand all the information”.  
Professional’s perception of shared decision making (SDM-Doc-Q) presented a 
score of   80.2 (19.7) for a maximum score of 100. The questions with higher 
scores were “Me and the patient planned for a follow up contact”; “I discussed 
 
Depression 
subscale 
Anxiety 
subscale 
Emotional Distress 
(total) 
 N percent N percent N percent 
Normal 12 33,3% 6 16,7% 9 25,0% 
Mild 11 30,6% 6 16,7% 4 11,1% 
Moderate 6 16,7% 9 25,0% 14 38,9% 
Severe 6 16,7% 14 38,9% 8 22,2% 
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with the patient the difficulties she/he might have in following treatment” and “I 
made clear to my patient that a decision needs to be made”. No differences were 
found regarding patient’s gender. 
 Table 4: SDM-Q scores   
  
 
N Mean 
Q1 “My doctor made clear that a decision 
needs to be made.” 
SDM-9-Q 36 
4.3 
(1.5) 
“I made clear to my patient that a decision 
needs to be made.” 
SDM-Doc 
-Q 
10 
4.3 
(0.7) 
Q2 “My doctor wanted to know exactly how I 
want to be involved in making the 
decision.” 
SDM-9-Q 35 
4.0 
(1.6) 
“I wanted to know exactly from my patient 
how he/she wants to be involved in 
making the decision.” 
SDM-Doc-
Q 
10 
3.8 
(0.6) 
Q3 “My doctor told me that there are different 
options for treating my medical condition.” 
SDM-9-Q 35 
3.3 
(1.9) 
“I told my patient that there are different 
options for treating his/her medical 
condition.” 
SDM-Doc-
Q 
10 
3.8 
(0.9) 
Q4 “My doctor precisely explained the 
advantages and disadvantages of the 
treatment options.” 
SDM-9-Q 35 
3.6 
(1.8) 
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“I precisely explained the advantages and 
disadvantages of the treatment options to 
my patient.” 
SDM-Doc-
Q 
10 
3.9 
(1.1) 
Q5 “My doctor helped me understand all the 
information.” 
SDM-9-Q 35 
4.5 
(1.2) 
“I helped my patient understand all the 
information.” 
SDM-Doc-
Q 
10 
4.1 
(0.7) 
Q6 “My doctor asked me which treatment 
option I prefer.”  
SDM-9-Q 36 
3.0 
(2.0) 
“I asked my patient which treatment 
option he/she prefers.” 
SDM-Doc-
Q 
10 
3.9 
(1.0) 
Q7 “My doctor and I thoroughly weighed the 
different treatment options.” 
SDM-9-Q 35 
3.2 
(1.9) 
“My patient and I thoroughly weighed the 
different treatment options.” 
SDM-Doc-
Q 
10 
3.7 
(0.8) 
QA1* “My doctor and I discussed the difficulties 
I might have in following with treatment.”  
SDM-9-Q 35 
4.6 
(1.0) 
“I discussed with the patient the difficulties 
he/she might have in following with 
treatment”. 
SDM-Doc-
Q 
10 
4.4 
(0.8) 
Q8 “My doctor and I selected a treatment 
option together.”  
SDM-9-Q 36 
3.3 
(2.0) 
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“My patient and I selected a treatment 
option together.” 
SDM-Doc-
Q 
10 
3.7 
(0.8) 
QA2* “My physician gave me his/her opinion on 
the best treatment for me.” 
SDM-9-Q 36 
3.7 
(1.9) 
“I gave the patient my opinion on the best 
treatment for him/her.” 
SDM-Doc-
Q 
10 
3.7 
(0.9) 
Q9 “My doctor and I reached an agreement 
on how to proceed.”  
SDM-9-Q 35 
4.1 
(1.5) 
“My patient and I reached an agreement 
on how to proceed.” 
SDM-Doc-
Q 
10 
4.2 
(0.6) 
QA3* “My physician and I planned for a follow-
up contact.” 
SDM-9-Q 36 
4.8 
(0.5) 
“My patient and I planned for a follow-up 
contact.” 
SDM-Doc-
Q 
10 
4.6 
(0.7) 
*QA1-3 are added questions to the original questionnaire, vide Methods 
 
3.4. Patients’ preferences on decision-making  
Regarding patient’s preferences, CPS presented a mean score of 6.9 (1.8), 
significantly higher than the patient’s perceptions score (p=.005). Patients that 
preferred a collaborative model, choosing options 2-4 in the CPS scale, were 
older (p=.029) with a mean age of 45.1 (11.2) years. Patients attending their first 
consultation with the psychiatrist, report higher preferences for SDM (p=0.018), 
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with mean CPS scores of 6.0 (1.6). No differences were found regarding gender 
or education level. 
Table 5: CPS scores    
 Patient’s 
Preferences 
Patient’s 
Perceptions 
Physician’s 
Perceptions 
 N (%) N (%) N (%) 
1. “I prefer to make the ﬁnal selection about 
which treatment will receive.” 
0 (0.0%) 0 (0.0%) 0 (0.0%) 
2. “I prefer to make the ﬁnal selection of my 
treatment after seriously considering my 
doctor’s opinion.” 
1 (2.8%) 2 (5.6%) 2 (18.2%) 
3. “I prefer that my doctor and I share 
responsibility for deciding which treatment is 
best for me.” 
11 (30.6%) 16 (44.4%) 0 (0.0%) 
4. “I prefer that my doctor make the ﬁnal decision 
about which treatment will be used but 
seriously consider my opinion.” 
19 (52.8%) 12 (33.3%) 8 (72.7%) 
5. “I prefer to leave all decisions regarding my 
treatment to my doctor.” 
5 (13.9%) 6 (16.7%) 1 (9.1%) 
3.5. Clinical relationship evaluation  
A mean score of 88.4 (11.3) was found in ARM, for a maximum value of 100. 
Mean scores of 91.7 (SD 11.5) and 79.2 (SD 22.1) were found in the ARM-CA 
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and ARM-O subscales. Female participants presented a tendency to lower 
scores on ARM-O (p=.055). Statistically significant lower score in ARM (p=.001) 
and ARM-CA (p=.008) were obtained in patients with higher HADS-D scores. No 
differences were found regarding age or education level. 
3.6.  Correlation analysis 
Patient perception of SDM behaviors in the consultation (SDM-9-Q) was 
significantly positively correlated with ARM-T subscale (r= .513; p=.002) and 
ARM-CA (r=575;          p=.000).  
Depression severity was negatively correlated with the development of a 
therapeutic alliance between patient and physician: ARM-CA (r=-.428; p=.012) 
and ARM-O (r=-.490; p=.003). The severity of depressive symptoms also showed 
a negative correlation with educational achievement (r=-.578; p<.001). 
4. Discussion and Conclusion 
4.1. Discussion 
Recovery from depression may be hampered by several factors as described by 
Van Grieken and colleagues [77]. “Lack of clarity and consensus regarding the 
nature of the disorder and its treatment between patients and clinicians” and 
“precarious relationship with the clinician” both relating to SDM – either to the 
process itself, or to its outcomes, may delay clinical recovery. In depressive care 
SDM is only recently being discussed with few information available on the 
preferences and behaviors of patients and physicians. The majority of patients 
we studied seem to be aware of their decisional preferences and attentive to 
physician’s behaviors in the clinical encounter. They report a desire for 
involvement in the decisional process, in agreement with previous findings 
regarding patient’s involvement in treatment decisions about depression [18]. In 
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the present study, both patients and physicians state an ample use of SDM 
behaviors within the consultation setting, with a positive association between 
SDM behaviors and an enhanced therapeutic alliance. This suggests that 
patients interested in a collaborative approach are satisfied when included in the 
decision-making process, establishing a good and fruitful relationship, which is 
by itself a favorable clinical outcome, related furthermore to other therapeutic 
outcomes.  
However, we found that patients considered physician unable to elicit their 
preferred treatment option, and in general lower scores in the SDM behaviors 
were related to discussion and selection of treatment options. This might relate 
to the need to improve physician’s ability to communicate and negotiate a 
treatment plan with the patients. Communication skills as the use of simple 
language, ability to negotiate and provide information were already mentioned by 
physicians as facilitating a more co-operative relationship and simplify the 
decision-making task [9]. Physicians seem aware of scarcely weighing the 
different treatment options with the patient. Interestingly, physicians also report 
lower scores in the disclosure of his personal opinion on the best treatment. A 
initial collaborative approach does not require exhaustive information to the 
patient, but instead a clear communication about therapeutics (treatment doses, 
time needed for the therapeutic response, potential side effects and ways to 
alleviate them, expected length of treatment, general idea of drug mechanism 
and action)[78]. 
Our findings suggest that those with severest illness experience less participation 
in the decision process. This may be explained by the advanced illness and 
significant depressive symptomatology, preventing patient’s engagement in SDM 
behaviors as much as their less severe counterparts. Feelings of helplessness 
and hopelessness, may play a role inhibiting active participation of depressed 
21 
 
populations in different therapeutic strategies[79]. Severely depressed subjects 
were also significantly older and less educated, more prone to assume a 
dependent and submissive position which also might have influenced the 
adoption of a SDM model, and heighten the correlation exposed.  Furthermore 
this group of patients being excluded from the decisional process, are refrained 
from the establishment of a productive therapeutic alliance, as shown by the 
lower satisfaction with the clinical relationship in this population.  We may 
hypothesize that insecure physicians are reluctant in abiding some of the 
decisional power in more clinically severe conditions, establishing poorer 
relationships with their patients.  
Previous research reports higher desire to participate in decisions in patients with 
younger age [10, 80], higher education and female gender[6]. In our study, we 
found a tendency for older people to prefer a collaborative approach, contrary to 
studies that have suggested older patients to be more likely to accept a more 
traditional, dominant role for the physician [81]. However, this subgroup was also 
the most severely ill, and this results may be influenced by this characteristic. 
Similar levels of preferred and experienced SDM were found in male and female 
participants. Lower therapeutic alliance scores were found in the female 
subsample, mainly in the openness subscale, suggesting that female depressed 
patients feel less comfortable with disclosure within the consultation setting. 
Whether this is a particularity of the population of depressed patients, a 
characteristic of our sample, or a reaction to different professional-patient gender, 
remains unclear. It may be relevant to note the different proportion of female-to-
male subjects in the professional and patient’s sample. We did not confirmed in 
our sample previous findings of different attitudes towards SDM according 
educational level. 
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Patients who first meet the psychiatrist tend to prefer a more participative role in 
the decisional process. This may possibly translate the need for time and 
experience to build a secure, trustful and assuring relationship. This contrasts to 
what is described in literature, which suggests higher desire to participate in those 
with greater experience of illness [10, 80]. However, they seem not to engage in 
more SDM behaviors, demonstrating a gap between preferences and active 
behavior. Future investigation should address the barriers associated with this 
withdraw from the decisional arena.  
This study presents several limitations. The reduced sample sizes does not 
permit the generalization of results. Constraints posed upon psychiatric practice 
in a state hospital (e.g.: time constraints) may have detracted the sample and 
reduced the collaboration of patients and psychiatrists. Other limitation relate to 
the eventual different presentations, symptoms and prognosis of depressive 
illness included in our study, informing different perspectives on information 
seeking behaviors. Further studies with more strict clinical characterization can 
help to discern the role of different depressive disorder subtype in SDM 
preferences and experiences. Regarding the physician group, most of them were 
interns. This characteristic may hinder the possibility to generalize the results to 
the general population of more experienced psychiatrists, but may translates 
accurately the perceptions of the young practitioners. 
4.2. Conclusion 
The results obtained suggest that patients with depression do not desire a full 
SDM approach, but are comfortable when such behaviors are present in the 
consultation. Patients tend to demonstrate their preferences for an informed 
model of decision making, where their input is taken into account, but ultimately 
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the decisions are relied to the psychiatrist. Their clinical experience however 
reveals a more participative role, congruent with physicians’ perceptions.  
Good therapeutic alliance scores were obtained suggesting that patients are 
satisfied with the approach psychiatrist assumes in practice. However severity of 
illness was negatively correlated with SDM behaviors, with the most severely ill 
reporting lower quality of patient-physician relationship.   
Patient’s, and physicians’, decision aids may play an important role in enabling 
both psychiatrist and patients in the decision process, as do improved 
communication skills. A detailed analysis of specific SDM behaviors suggest that 
physicians can improve their ability to communicate and to involve patients in 
therapeutic decisions. Several interventions to improve capacities and active 
engagement in decisional labor, have been suggested by others, either in 
physicians - improvement of clinicians skills [82],  and in patients - patient 
decision aids [2, 3, 82], communication skills programs [82, 83], and individual 
preparation.  
Further studies may explore the relation of SDM behaviors with clinical outcomes 
in depressed patients, and the impact of educational measures and decisional 
aids on both physicians’ and patients behaviors. Barriers and facilitators to SDM 
in this specific population should also be addressed. 
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ABSTRACT  
 
The clinical decision process is central to the patient-physician relationship. The 
paternalistic approach, once the preferential model of medical practice is now under 
severe criticism. Clinicians find themselves trying to find alternative models where the 
physician is not a sole source of information as in an Informed Decision Model, nor an 
agent to interpret the will and decide by the patient as in a Doctor-as-Agent Model. The 
Shared-Decision Model is in line with this endeavor, inviting the patient and physician to 
be co-responsible with the information exchange and treatment plan.  
This model, based on strong communication ability, shows particular interest in the 
decisions that are sensitive to personal preferences and entail some degree of 
uncertainty – as the majority of the decisions made in the psychiatric field. Furthermore 
depression is thought to place patient’s capability to decide at risk. The research shows 
however that patients with depression still want to participate in the clinical decisions, and 
reports a positive impact of using this model on the compliance with the therapeutic plan, 
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in a decreased need of hospitalization and in better knowledge of the illness and higher 
satisfaction with health services. Shared-decision appears to be of additional interest, 
once it promotes the sense of autonomy and self-efficacy, decreasing feelings of 
helplessness and hopelessness associated with depressive state.  
We performed a review of the models of decision making and its application to psychiatric 
patients. The reviewed literature permited to uncover the model characteristics more 
suitable to application in depressed patients and their physicians in the decision process. 
When dealing with patients with depression, sharing technical knowledge and information 
and the joined participation in the process of decision seems to be welcomed, and even 
desired. Results highlight the influence of a Shared-Decision Model on patient’s 
satisfaction and compliance with treatment. 
 
Keywords: decision-making, depression 
 
 
INTRODUCTION 
 
The patient-physician interaction is an essential component of medical practice. Central 
to this interaction is the communication between both and the relationship established. 
Patients come into clinical settings commonly seeking help, either searching for 
information or care, mostly in the search for a solution to their problem. However, the 
process of finding the right treatment and the answer for this endeavors is not 
straightforward and is largely dependent on the patient, the physician and the clinical 
situation.  
Several decision-making processes have been described: from a paternalistic approach, 
built over an authoritarian view of the patient-physician relationship, to more 
contemporary models of shared decision-making, where a joint and co-responsible 
decision is aimed. The research on the decision making process, and its goals, has been 
done in parallel to the evolution of models of patient-physician relationship, highlighting 
how both influence and enable each other. 
Physicians were historically seen as the embodiment of wisdom, alike ancient priests 
with almost divine powers. The ancient religious leaders helped the populations by 
translating god’s laws. Every ail, health-related or otherwise, was seen as a fault, and for 
each fault there was an atonement in order. Dealing with eternal and unchanging laws, 
there was no place for negotiation between the sinful and the deity, just submission and 
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expiation. With the dawn of Positivism, illnesses were no longer seen as punishments. 
The disease state became ‘notisfault’[1] and so medicine began to brew new 
explanations and causality inferences between organic derangements and disease. This 
time, the knowledge of the physician did not came from the heavens, but was funded on 
scientific knowledge. However, still as hermeneutic and inaccessible for the layman as 
before. This is the relationship that Parson described in the 1950’s, an interaction where 
the patient was committed to the passivity of the ‘sick role’. Parson [1] describes a 
helpless patient, whose technical incompetence hinders any chance of extricating out of 
illness by his own effort. In this paradigm, the physician is responsible for the welfare of 
patient, in line with a Paternalistic Model of decision-making. However this model 
imposes a considerable burden to physicians in conditions which are known to be 
uncontrollable or with a high degree of uncertainty. 
 
 
Evidence-Based Medicine and Patient-Centered Care 
 
Contemporary clinical practice is strongly influenced by empirical science, used as an 
explicit basis for making judgements about the provision of clinical care [2]. This model 
assumes that whatever treatment shown to be the most effective is the ‘rational’ choice 
to implement, and ‘if an informed patient with expressed desire to get well chooses a 
different treatment this choice must be the result of wither unusual or irrational thinking 
’[3]. Taken to extreme, evidence-based decision-making has been associated with 
rational decision-making, in which choices made by patients which deviate from the 
scientific evidence are labelled as irrational, from which the patient must be protected. 
With the proposal of the biopsychosocial model of illness, which also emphasized the 
importance of psychosocial factors in the course of illness, the patient’s experience of 
illness acquired a central role in decision-making [4]. The ilness centered-care paradigm 
was replaced by the patient-centered medicine, dethroning the scientific perspective and 
moving the patient from the periphery to the center of medical decision making [5]. 
Patient-centered care withdraw health care from the exclusive focus on symptoms and 
physiological outcomes, taking into account that patients often value functional outcomes 
and quality of life higher  than control of illness. This challenges a science-based 
paradigm, assuming that the clients are the best judges of their own needs.  
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Formerly incompatible with either a shared or an informed model of clinical decision-
making, the evidence-based approach is being redefined, considering that the scientific 
information is not exclusively advantageous to find a treatment option, but rather to help 
create more informed patients and enhance patient choice [6]. Intermingled with the 
principles of patient-centeredness, evidence-based medicine now assumes that client 
preferences, expressed as informed choices, outweigh scientific evidence [4]. 
 
 
Models of Patient-Physician Relationship 
 
Medical treatments have become increasingly technologically complex and there is 
expected that they are justified by scientific evidence. However, taking into account the 
limitations of empirical health research, the patient-physician relationship has become 
increasingly valuable [7]. Contemporary with Parson, Szasz and Hollander [8] described 
three basic models of doctor-patient relationship, which translate into different 
approaches to treatment [8] – Table 1. The first model assumes that in some instances 
it might not be possible for the patient to participate in the relationship and the physician 
acquires an authoritarian posture - the Activity-Passivity Model. Conceptually, there is 
no interaction between patient and physician, since he is unable to contribute. 
Nowadays, with the increasing use of advance directives, this model may no longer be 
acceptable (even) in emergency situations. 
The other two models assume that an interaction is established, both participants are 
‘active’ in the sense that they contribute to what ensues from the relationship. However 
patient and physician’s functions differ: in the Guidance-Cooperation Model the main 
difference pertains to power, and to its actual or potential use – the patient is expected 
to ‘look up to’ and to ‘obey’ his doctor; in the Mutual Participation Model, the power is 
divided and the participants are mutually interdependent, engaging in an interaction 
satisfying for both. 
This last model is highly developed and pointed as ideal when dealing with chronic 
diseases, where the patient’s experience provides reliable and important clues for 
therapy. Moreover, the treatment program is carried out by the patient, so that the 
‘physician helps the patient to help himself’ [8]. The Mutual Participation Model requires 
a complex psychological and social organization of both participants, and, according to 
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Szasz and Hollander, ‘ is rarely appropriate for children or for those persons who are 
mentally deficient, very poorly educated, or profoundly immature’[8]. 
Those authors did not consider that patient’s participation might extend to involvement 
in treatment decisions, neither that he could ever assume a dominant role in decision-
making. Latter Freidson argued that the patient’s status may be equal to, or even higher 
than that of the doctor – as in private practice. However, neither predicted consumer 
sovereignty in publicly financed health services [9]. 
 
Table 1. Models of Physician-Patient Relationship and its’ concepts of 
“Treatment”/“Therapeutic Result”  
 
Model 
Physician’s/ 
Patient’s Role 
Clinical 
Application of 
Model 
Meaning of 
“Treatment” 
Meaning of 
“Therapeutic 
Result” 
Activity-
Passivity 
Does 
something to 
patient/ 
Recipient (inert 
or 
unresponsive) 
 
1. Treatment of the 
unconscious 
patient; 
2. Major surgical 
operation under 
general anesthesia 
Whatever the 
physician does; 
the actual 
procedures 
which he 
employs 
Alteration in the 
structure and/or 
function of the 
patient’s body (or 
behavior, as 
determined by the 
physician); the 
patient’s 
judgment does 
not enter into the 
evaluation or 
results 
Guidance-
Cooperation 
Tells patient 
what to 
do/Cooperator 
(obeys) 
Most of general 
medicine and the 
post-operative care 
of surgical patients 
Patient’s 
judgement is not 
irrelevant; 
success of 
therapy is still the 
physician’s 
private decision; if 
patient agrees, he 
is a good patient, 
but if he disagrees 
he is bad or 
‘uncooperative’ 
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Mutual 
Participatio
n 
Helps patient to 
help himself/ 
Participant in 
partnership 
(uses expert 
help) 
The treatment of 
patients with certain 
chronic diseases or 
permanent 
structural defects 
An abstraction 
of one aspect of 
the relationship, 
embodying the 
activities of both 
participants; 
“treatment” 
does not take 
place unless 
both 
participants 
orient 
themselves to 
the task ahead 
Evaluation of the 
result will depend 
on both the 
physician's and 
the patient's 
judgments and is 
further 
complicated by 
the fact that these 
may change in the 
very process of 
treatment  
(Adapted from “A contribution to the philosophy of medicine; the basic models of the doctor-patient 
relationship.”, Szasz, T. S. and M. H. Hollender (1956). AMA Arch Intern Med 97(5): 585-592.) 
 
 
 
Compliance (vs) Concordance Paradigms 
 
Compliance is the degree a patient’s behavior corresponds to the physician’s 
prescription [10] and implies obedience to his authority [11], this definition highlights the 
power imbalance in the patient-physician relationship, hallmark of paternalistic models 
of medical practice, emphasizing pejorative obedience for the patient. It focuses more 
on behavior and less in the attitudes toward medication, failing to capture ‘the dynamic 
complexity of autonomous patients, who must navigate decisional conflicts in learning to 
manage disorders over the course of decades’[5].  
This paradigm has been criticized for being too simplistic to address the complex 
decision-making processes that are required to discover the optimal use of medication. 
It devaluates the patient’s role in health care decisions [5], blaming those who do not 
follow medical advice [12]. It assumes furthermore that the patient possess adequate 
information on the condition being treated and its treatment, has access to medication 
and the ability to take it as instructed, which is not always the case. Research that 
analyzed compliance from the patient’s perspective found that the main reason why 
people choose not to follow physician’s prescriptions concerned the drugs themselves 
[13]. Others were: as a way of expressing their attempts to cope with their disease, as a 
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reaction to the way they were treated by physicians, or as a way of fighting the system 
by breaking its symbolic rules [12].  
The more neutral concept of adherence aimed to surpass the concept of compliance, 
hoping that the term would not reflect the same degree of coercion [11]. Adherence 
definition according the World Health Organization is ‘the degree to which the person’s 
behavior corresponds with the agreed recommendations from a health care provider’. 
Although it implies a more collaborative perspective by integrating the physician’s 
medical opinion and the patient’s lifestyle, values and preferences, the underlying 
paternalism remained, and a new model of concordance was proposed.  
Concordance refers to ‘anticipated outcome of the consultation between doctors and 
patients about medicine taking, if both parties can be encouraged to work together as 
partners’. It differs from the previous concepts focusing on the consultation process 
rather than on a specific patient behavior, and has an underlying ethos of shared 
approach to decision-making [13, 14]. It advocates a sharing of power in the patient-
physician relationship, ensuring they have enough information to participate in making 
decisions about treatment and supporting them with any problems they might have. 
Stevenson [15] defines three necessary elements for the concordance practice: the 
evidence that patients share their beliefs, experiences and preferences, that physicians 
question about health care preferences and constraints on adherence and that a 
balanced discussion takes place between health care practitioners and patients. ‘It is a 
process, which entertains patients’ views on medication taking, and acknowledges that 
patients’ views have to be respected even if they make choices, which appear to be in 
conflict with the clinician’s views’ [16]. 
For this to be possible, doctors need to recognize patients’ decision-making abilities, to 
try to understand patients’ needs and constraints, and work with patients in the 
development of treatment regimens [12] - beyond a compliance paradigm, towards a 
therapeutic alliance – in line with share decision-making.  
 
 
MODELS OF CLINICAL DECISION-MAKING 
 
Increasing relevance is being attributed to the process of medical decision in clinical 
practice, which draws important characteristics from the interaction established. Several 
models of decision making have been identified, varying in the roles assumed by the 
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patient and the physician, the relative sharing of information and the decision-making 
power.  
Different models of treatment decision-making may be more or less appropriate, or 
feasible, in specific contexts (eg. emergency setting, long-term monitoring of medication 
in the treatment of chronic disorders, palliative care).  
The health-related decision-making process is composed of two steps. The first one 
involves the evaluation of scientific evidence requiring analytic skills with the prospect 
that an agreement can be reached [17]. The second step comprises the subjective 
evaluation of facts, integrating personal values and inclinations. In a patient-centered 
paradigm, this appraisal should draw from the patient’s preferences and be reflected into 
a meaningful decision. There are no correct answers, nor an obligation that an 
agreement is reached. The most prominent models of treatment decision-making are the 
Paternalistic, Informed and Shared-decision Models.  
 
 
1. Paternalistic Model of Decision-Making 
 
Sometimes called parental, or priestly model, it derives from the early conceptualization 
of the ‘sick role’. The physician is depicted as a guardian of the patient’s best interest, 
without the need to elicit the latter’s preferences. Submissiveness to professional 
authority is based on several assumptions [6]: 
 
1. It assumes that a single best treatment exists, and that there are objective criteria 
for determining what that is; 
2. Physicians know the best treatment available and consistently apply this 
knowledge when selecting treatments; 
3. Physicians are in the best position to evaluate the tradeoffs between different 
treatment and therefore to make the treatment decision; 
4. Physicians have a legitimate investment in each treatment decision, because of 
their professional concern for the welfare of their patients. 
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According to this model the patient assumes a passive role, in an encounter dominated 
by the physician, who uses his skills to diagnose and recommend test and treatments. If 
any, the patient involvement is limited to providing consent to these recommendations, 
thankful for the decisions made by the physician even if he would not agree to them at 
the time [12]. Differences in education, income and gender also contribute to this power 
disparity.  
With the increasing number of illnesses for which no best treatment existed, the 
decisional context evolved to considerer different treatments with different types of 
tradeoffs between benefits and risks. The widespread variations in clinical practice 
underlined the changeable scientific basis of much medical care and heightened the 
awareness that doctor’s values and beliefs influence clinical decisions [9]. Since the 
patient rather than the physician has to live with the consequences of the decisions, the 
assumption that the physician is in the best position to evaluate and weigh advantages 
and disadvantages was increasingly challenged [6]. The objectivity of the professionals 
has also been questioned given that several factors can cloud their objective judgement 
[7].  
This model has been considered inappropriate for many current treatment decision-
making contexts, and is presently limited to emergency situations, where the patient is 
not able to participate in the decision-making interaction, and there are no advance 
directives, or in the presence of incompetent patient without a guardian (e.g., under-aged 
people, some mentally ill patients). 
The instrumental model represents the extreme version of the paternalistic approach to 
clinical decision making. It rests on an abusive disregard to the patient’s values and well-
being, such as disrespectful or unethical human experimentation. According to this 
model the physician acts on behalf of a goal independent of the patient, such as the good 
of society or the progress of scientific knowledge [16].  
The logical next step appeared to be the patient empowerment in treatment decisions. 
Advocates of patient-centered care invoked two main arguments for increasing patient 
decisional-power [7]: a philosophical argument – the ethical principle of autonomy; and 
an economic argument – a free market concept where more consumer choice may 
increase standards through competition.  
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2. Informed Models of Decision-Making 
 
Several models were developed in reaction to the paternalistic model. The Informed 
Models of Decision Making emerged from the recognition of informational asymmetry 
between patient and physician – technical knowledge resided in one party of the 
interaction, while personal preferences reside in the other These models postulate that 
both types of information need to be combined in the provision of effective care [18].  
 
Informed Decision-Making Model 
This model emphasizes patient sovereignty and patients’ rights to make independent, 
autonomous choices. It embodies the adoption of business terms for medicine, as when 
physicians are described as health-care providers and patients as consumers [19]. This 
consumer oriented model, also called scientific or engineering model, rests on two 
assumptions [6]: 
 
1. Patients possession of current scientific information on treatment enables them 
to make the best decision for themselves; 
2. Physicians should not be involved in the decision-making process, since their 
interests and motivations may be different from the patients’. 
 
The role of the physician is limited to information exchange, communicating the needed 
technical or scientific knowledge to the patient. This is seen as an enabling strategy, 
reducing the asymmetry in the clinical relationship by increasing the patient’s knowledge. 
Patients should therefore be able to make decisions that reflect both their preferences 
and the best scientific knowledge available, no longer needing to share the treatment 
decision-making process.  
This model also assumes a ‘rational actor model’ of information transfer, which assumes 
that the evidence-based information provided is fully understood as stated. Scientific 
evidence in the form of probability statements is transferred to the patient, who is 
perceived as a passive and empty vessel. It leaves no active role for the patient to 
interpret the scientific information or to try to make it personally meaningful [20].  
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The informative physician lacks a caring approach that requires understanding of the 
patient values, and his proscribed from giving recommendation for fear of imposing his 
will on the patient and thereby competing for the decision-making control that has been 
given to him [3]. It does not consider that an informed patient may still prefer not to lead 
the treatment decision-making process, ignoring that they are often uncertain and have 
‘second order desires’, that is, the capacity to reflect on their wishes and to revise their 
own desires and preferences [3].  
For these reasons this model is now being criticized, justified only where there is a one-
time physician-patient interaction without an ongoing relationship in which the patient’s 
values can be elucidated. 
 
Interpretive Model 
In the Interpretive Model [21] the role of the physician remains an informative one, 
however, he also helps to elucidate the patient’s values and what he actually wants. It 
places the elucidation of values in the context of the patient’s medical condition at the 
center of the physician-patient interaction. The physician informs and helps the patient 
to understand and use these values in the medical situation, leaving to him the ultimate 
decision.  
The physician acts as a counselor, whose obligations include those enumerated in the 
informative model but also require engaging the patient in a joint process of self-
understanding leading to autonomy.  
 
Deliberate Model  
According to this decision-making decision process [21] the physician acts as a teacher 
or friend, engaging the patient in a dialogue on what course of action would be best. The 
physician using no more than moral persuasion aims to suggest why certain health 
related values are more worthy and should be aspired to. Here, the conception of 
autonomy is moral self-development. The patient is empowered not to simply follow 
unexamined preferences or examined values, but to consider, through dialogue, 
alternative health related values, their worthiness and implications for treatment. 
In this model the physician’s values are relevant to patients. They inform their choice as 
a physician, who would not only help fit therapies to the patient’s elucidated values, but 
also promote health-related principles. It embodies an ideal of a caring physician who 
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integrates the information and relevant tenets to make a recommendation and, through 
discussion, attempts to persuade the patient to accept this recommendation.  
 
Professional-As-Agent Model 
Derived from economics, this model also resolves the asymmetry between the physician 
and patient, this time with information transfer from the patient to the physician. The 
patient gives information regarding self-knowledge, that the physician has no other way 
of knowing. The physician’s role is one of an agent ‘trying to choose what the patient 
would have chosen, had he been as well-informed as the professional’[18]. The decision-
making process is restricted to the physician, who is refrained from using his preferences 
– the only preferences that matter are those of the patient. The professional makes the 
decision, either assuming that they know, or having elicited the patient’s preferences [2]. 
 
 
3. Collaborative Models of Decision-Making 
 
The information sharing from the physician to the patient does not lead to a sharing of 
the decision-making process. This notion of two separate goals in the medical encounter 
– information sharing and decision-making sharing contributed to the emergence of a 
effective shared model of decision-making [18]. 
 
Shared-Decision Model 
The Shared Decision-Making (SDM) model refers to a patient-physician 
communicational process, as part of the healthcare delivery, in which both participants 
collaborate to access information and enable health care decisions to be made [22]. 
Patient participation in the decision-making process regarding medical treatment 
encompasses a number of interests [2, 18]: 
 
1. Legal - Widespread obligation of informed consent registry implies a minimum of 
shared decision-making; 
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2. Ethical - The emergence of consumer rights movement and the call for patients’ 
autonomy, demands for a shared process that goes beyond informed consent to 
include broader principles of patient autonomy and control; 
3. Clinical – With the shift in the nature of medical practice, from an acute to a more 
chronic care, caregivers often manage illnesses or combinations of illnesses 
rather than cure disease, which poses decisional challenges not solved by the 
sole use of empirical evidence. 
 
This model seems to be of special interest when decisions are sensitive to personal 
preferences, such as facing uncertain or equivocal evidence of benefit [2]. In the 
management of chronic illness the patient necessarily is responsible for his own care [4]. 
To manage his condition, decision-making almost always involves different possibilities 
with different possible outcomes, and substantial uncertainty regarding impact on 
physical and psychological wellbeing [18]. 
Charles [18] sets four necessary criteria for classifying a physician-patient decision-
making interaction as a Shared Decision-Making process: 1. Quorum - it must involve at 
least two active participants, comfortable with their level of participation; 2. Information 
exchange - both the physician and the patient share information; 3. Joint deliberation - 
both parties participate in the process of decision, expressing treatment preferences; 
and 4. Decision - a treatment decision is made upon the agreement of both parties. 
To the active involvement of the two participants it is essential the respect for the patient’s 
preferences. The physician must first elicit patient’s preferences for participation in the 
decision-making process, give choices as to how this process will proceed and then 
respect patient’s choices by behaving accordingly [18]. Research on patient’s attitudes 
towards medical care revealed that patient vary in their preferred role in medical decision 
and they want to choose a physician with whom they can have a trusting relationship [4]. 
Preferences for involvement may also fluctuate over time or depending on 
circumstances. Patients who express preferences for some form of shared decision-
making do not necessarily act accordingly in the medical encounter. Therefore, 
physicians should regularly review patient’s changing preferences for involvement, 
familiarizing themselves with the competing demands they experience at each decision-
making stage [2] and consider situational factors surrounding the doctor-patient 
interaction [21].  
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Some patients prefer a passive role in the decision-making process [17]. In a study by 
Degner [23], 15% of participants believed that they had been forced to assume more 
responsibility for the decision than they were comfortable with. Those who prefer a more 
active role tend to be younger, more educated and healthier [9]. People with serious and 
chronic illnesses or older are less likely to prefer an active role in choosing treatments 
[5]. Older patients passivity may be explained by a cohort effect – they are cultural prone 
to see the doctor as a traditional power figure, a aging effect – they tend to rely more on 
the expertise of others and desire less responsibility in medical care, and/or a companion 
effect – they are more often accompanied by others participating in the decision-making 
process instead of the patient. Limiting the conceptualization of SDM to a dyad may not 
reflect the current realities of clinical practice. The physician-patient interaction often 
involves more participants, with different patients, physicians, as well as relatives and 
friends. The range of interactional dynamics is automatically increased, and enables the 
formation of coalitions that will vary depending of the decisional context [18].  
It is not always clear what type and amount of information patients want, or why they 
want it. Research suggests that physicians misestimate patient’s preferences for 
information [24]. They are not so much interested in average outcomes for aggregate 
groups of patients as they are in knowing what this information means for themselves. 
Patients interpret information in order to make them personally meaningful [25]. They 
combine medical advice with information from other sources, ranging from health 
education campaigns and media articles to folklore and conversations with friends. All 
these sources are weighed in order to fit the patient’s circumstances. Furthermore 
patients will use their own expertise about society and everyday life to decide how to use 
the medical information available [26]. 
Both patient and physician are required to bring their own expertise to the decision-
process, sharing technical knowledge and personal information from both parties. 
Patients are increasingly literate in medical knowledge, and it is crucial for the physician 
to ascertain this health-related beliefs. Physicians’ values are also important in that they 
enable the building of a professional opinion, not only based on raw empirical evidence, 
but on clinical and personal experience. This helps to bridge the empirical evidence base, 
which is established on population averages, with the unique concerns, values and life 
context of the individual patient [5]. On the other hand the value of information from the 
patient’s perspective does not lie solely in its potential use as an aid to decision-making, 
but also as a psychological reassurance, reducing uncertainty at a time of great stress 
and vulnerability [27].  
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Agreement between physician and patient about the treatment decision is one possible 
outcome of a shared process; others include no decision or disagreement as to the 
preferred treatment. A shared decision does not mean that both parties are necessarily 
convinced that this is the best treatment possible, but rather endorse it as the treatment 
to implement - through mutual acceptance both parties share responsibility for the final 
decision [18]. 
With emphasis on interaction, based on the bidirectional exchange of information and 
joint process of deliberation, this model is likely to be more complex and time consuming 
than either the paternalistic or informed approaches, each of which require less 
interaction and consensus building [6]. SDM encourages a dialogue between patient and 
clinician to clarify overt and covert intervenient factors – socio-demographic and cultural, 
so as to reach treatment decisions which the patient will likely implement. 
A number a benefits have been reported when shared decision-making is applied. From 
the clinical perspective, improvements in the therapeutic relationship as well as in a 
variety of health outcomes such as treatment adherence, satisfaction and biomedical 
outcomes were found. Patients who performed the decision-making role tend to be more 
satisfied and present a higher functional status. Surveys also demonstrate that near the 
totality of patient desire information on relevant healthcare problems and many want to 
participate in health care decisions. The application of a shared decision model also 
possesses economic advantages - as a consumer patient’s control represents a mean 
of tying the healthcare industry into a form of market discipline. From a theoretical and 
ethical point of view shared decision-making is an end in itself due to the assumption 
that people with illnesses should determine what happens to their bodies and are best 
suited to make the decisions because only they can place personal values on the 
outcomes. 
Concerns on possible disadvantages of offering patients a shared process of information 
exchange and decision have also been suggested [4, 9, 28-30]: 
 
1. Sense of overwhelming – Choices can be debilitating for those who have difficulty 
with important decisions; 
2. Fear of decision regret/Increased sense of lost opportunities – Patients may 
experience regret or reject options to spare themselves the possibility of regret; 
3. Difficulty in valuing outcomes – Patients may be unable to anticipate how they 
will adapt to illness or react to treatment; 
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4. Dissatisfaction with clinical realities – The expectation of choice and decisional 
control may lead to dissatisfaction when expectations meet clinical realities; 
5. Discomfort with assuming unsought responsibility; 
6. Nocebo effect – Disclosing information about risks may increase the experience 
of adverse effects due to suggestibility; 
7. Impracticability – Unfeasibility to provide information on the potential risks and 
benefits of all treatment options available; 
8. Utopic usage of resources – Greater patient involvement in decision-making may 
lead to a greater demand for unnecessary, costly or harmful procedures which 
could undermine the equitable allocation of health resources; 
 
There are situations in which shared decision making is not fully applicable, such as in 
emergency situations or in situations in which there is a decisional incapacity. In these 
situations, advance directives can help to protect the patient autonomy and provide 
practitioners with a guide to making treatment decisions that are conducted by the clients’ 
preference and values – a method consistent with client-centered care and SDM [5]. 
Several interventions to improve patient’s decisional capacities have been suggested, 
either from the physicians (e.g., improvement of clinicians skills [18]) or from the patients 
perspective (e.g., patient decision aids [2, 6, 18], communication skills programs [18, 31], 
individual preparation of patients). 
 
 
DECISION-MAKING IN PSYCHIATRY 
 
Since 1970s, the process of negotiating a treatment approach, with the attainment of a 
mutually acceptable option between the patient and the physician, has been discussed 
in psychiatry. The roles played and the imbalance of power between physicians and 
patients, have been questioned with the rising of cultural and professional movements 
such as the anti-psychiatry movement, consumer-led services, the alternative treatment 
movement and the critical psychiatry networks [7]. The evolving policy of informed 
consent including patient’s values define physicians interventions aiming to enhance 
patient’s control over their options, treatment, health and lives [32]. The participation of 
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patients in medical decisions affecting their treatment is increasingly being advocated in 
the field of mental health [33]. This desire and the need to frame medication within the 
context of the client’s desires, life goals and history, brought the concept of therapeutic 
alliance to the frontline of psychiatric practice [5]. This alliance implies a collaborative 
approach, based on co-responsibility and trust, hopefully translating into better clinical 
and personal outcomes, with careful consideration of both consumer and provider 
perspectives.  
Most studies show that people with mental illnesses are interested in being involved in 
the management of their conditions, and welcome opportunities to be informed and share 
the process of decision-making [2, 6, 34]. Patients consistently report positive attitudes 
towards shared-decision making [32, 35, 36], with levels of interest higher than those 
experienced [6, 37, 38][39]; and similar [36] or higher [33, 38] than patients with somatic 
diseases.  
The patient’s desire to be informed about his mental condition and treatment has been 
shown to be higher than the desire to participate in decision-making [33, 40, 41]. They 
seek information about their illness, welcome scientific evidence and like to be kept up-
to-date about illness and treatment as well as other supports within the mental health 
system [42]. This information is frequently not volunteered by physicians or other health 
professionals [39], forcing patient to be proactive in obtaining information, either in the 
consultation, or with other professionals, family, social contacts, and/or digital resources. 
Similar levels of desire for information were found in all ages [43]. However the decision 
aid material created for general health does not translate perfectly to mental health. The 
power differential, coupled with providers’ ability to use legal means to override 
consumer preferences, creates a different dynamic in psychiatric practice [44]. There is 
moreover a lack of instructions to providers on the use of such aids, and the limited 
technical assistance makes them difficult to implement. 
Decisional conflict in psychiatric patients may be explained by stigma, symptom 
suppression, and delayed onset of consequences due to discontinuation of medicine. 
This highlights the need for support resolving the ambivalence regarding the use of 
psychiatric medications or other therapeutic tools [5].  
Patients have a strong desire to be involved in decisions about their medications [38] but 
fear taking full control or responsibility over the decision taken or the treatment to follow 
[33, 36]. They wish a collaborative approach [45], rather than an informative or 
paternalistic model. A tendency to prefer a lesser role in the decision-making process 
was exclusively found when more severe clinical pictures were present [45].  
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Preferences appear to vary in relation to the type of decision being made. Patients prefer 
to assume a collaborative role when facing psychiatric medications, an autonomous role 
for decisions related to psychosocial interventions, and a passive role with their primary 
care provider [38, 43]. Psychiatrists, on the other hand consider psychosocial and 
lifestyle issues to be more suitable for shared decision-making than medical or legal 
decisions [46].  
Differences in participation preferences across different psychiatric conditions are 
negligible [36] and demographic or situational variables explain less than 20% of the 
variability in decision-making preferences [47]. Research reports higher desire to 
participate in decisions in patients with: 
 
1. Experience of involuntary treatment [33] - In mental health some patients may be 
forced to treatment, but even those treated involuntarily some degree of 
autonomous choice is possible. This partial inclusion in treatment decisions may 
improve their attitude toward treatment and thus enhance compliance.  
2. Negative attitudes toward treatment [33] - Patients unsatisfied with treatment, 
namely those with less insight into the necessity of treatment [37], expectation of 
side effects or uncertain of treatment benefits [32], are more likely to non-
adherent. When dealing with patients with poor insight and negative drug 
attitudes, psychiatrists tend to use authoritative decision-making styles despite 
the patient desire to participate [37]. 
3. Younger age [40, 45] - Studies report higher desire to participate in younger 
patients or in those with greater experience of living with illness. Others suggest 
that older adults are more likely to experience a passive role in psychiatry 
medication decisions [43]. 
4. Female gender [36] 
5. Higher education [36] 
 
Regarding mental health problems SDM is being practiced at the level of information 
exchange in both psychiatric and primary care setting [48]. Observational studies 
accurately assessing the SDM process in mental health consultations have found that 
the majority of professionals do not objectively favor involving the patient in the decision-
making process [49-53]. Physicians report higher levels of patient’s participation than 
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those experienced by the patient, who state little meaningful input into major decisions, 
especially about medications [37, 44].  
This discrepancy underscores the importance of explicitly inquiring the patient’s 
preference in the decision-making process. Occasionally professionals, even if 
interested in a SDM process, resist directly asking patients about their preferences for 
involvement in decision-making [49] and describe to intuitively feel if the patient is able 
and interested in participating. Some investigators explain this behavior as a defensive 
routine, managing the environment unilaterally and controlling the task [49]. When 
patients initiate discussion about treatment options, however, physicians respond with 
greater patient involvement [52].  
Taking into account patient preferences in treatment planning and delivery has been 
associated with several positive outcomes [44, 54], namely greater knowledge, 
satisfaction with treatment, feelings of being helped, involvement and activation of 
decision-making and improvement of treatment adherence with lower need for re-
hospitalization [55-57].  
Nonadherence to treatment in mental health is high and the lowest adherence rates are 
found in chronic conditions, when treatment is prophylactic or suppressive or the 
consequences of stopping treatment are delayed [58, 59]. Decisions regarding treatment 
are moreover influenced by patient’s expectations, attributions and beliefs, as 
exemplified below:  
 
1. The patient may perceive treatment as “worse” than the disorder [5, 39, 60], either 
by the presence of intolerable side effects or by the experience of a 
transformation of self into a “drugged me” or a “not-me”; 
2. Using medication is seen as not worth the discrimination and social rejection 
associated [13, 39, 61, 62]; 
3. Treatment is an unwanted reminder of illness [63]; 
4. There is no need for treatment because they are not certain of being actually ill 
[13, 63]; 
5. Medications is needed to deal exclusively with specific symptoms, or when the 
symptoms are present and experienced as distressing; 
6. It is best not to use medications because it is ineffective [64]. 
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The concept of shared-decision making is also relevant to health decisions such as 
lifestyle modifications. Given the high morbidity and mortality of psychiatric populations, 
and the deleterious effects of psychiatric medication, promoting healthy lifestyles can 
have a major impact [64]. The model allows the physician to help the patient to identify 
personal resources as self-initiated, non-pharmaceutical self-care activities that serve to 
decrease symptoms, avoid undesirable outcomes such as hospitalization, and improve 
mood, thoughts, behaviors and wellbeing [60]. Nevertheless patients do not routinely 
disclose their personal resources and coping mechanisms to physicians and physicians 
do not routinely inquire about them. These strategies optimize the process of managing 
illness and promote health [45].  Physicians should learn to monitor their use.  
The Recovery Model applied to mental health emphasizes and supports each individual’s 
potential for recovery, seen as a personal journey that involves choice, self-
determination, and empowerment [2]. Mastering a sense of self-efficacy that fostered 
accomplishment, control, and improvement in one’s life have been found to be essential 
to recovery in psychiatric disorders [65]. A mismatch between treatment priorities and 
needs of patients with serious and persistent mental illness results in a fail to provide 
integration in the community [66]. Conversely, patient’s participation in the decision-
making process contribute to his autonomy and reinforce self-confidence.  
Research reports diverse, and sometimes contradictory results regarding outcomes 
associated with SDM. There is a tendency to consider the shared approach to decision 
making as beneficial regarding commitment to therapy [67, 68], but no clear effects on 
clinical outcomes have been fond [7, 67, 69-71]. Chan and Mak described in 2012 four 
ways in which share decision-making could play a role in promoting aspects of mental 
health recovery [22]: 
  
1. In the personal involvement and intimate commitment to the process of illness 
management and recovery. A recovery-oriented dialogue links the patients lived 
experience to their own concepts and understanding of recovery, and with this a 
new personal vision can be created, constituting a self-transformation of the 
patient. A recovery-oriented care for people with severe mental illness implies 
that the person in treatment should have the greatest role possible in 
collaborating with the provider to define the goals of treatment and plan for ways 
to reach these goals [72]. 
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2. Empowerment and reinforcement of a sense of self-direction. Patients with 
severe psychiatric symptoms seem to be less empowered and experience 
diminished self-confidence, which was not found to be correlated with global 
functioning. Instead, those with larger social support network reported more self-
orientation to empowerment [73], including self-esteem and efficacy, community 
confidence and optimism. Greater self-orientation was associated with better 
quality of life, fewer symptoms and better social support [73]. The impact of 
empowerment on the community is manifested by the patients’ desire to change 
his stigmatizing community. Patients believe they have some power within 
society, are interested in affecting change, and wish to promote community action 
[73].  
3. Improvement of patient-physician relationship, by reducing the informational and 
decision-making asymmetry. Therapeutic relationship is an independent 
predictor of treatment outcome, a mediating factor that captures significant 
variance in the outcome of treatment interventions such as pharmacological 
therapies, and an outcome per se [74]. Schizophrenic patients who formed good 
therapeutic alliances with their therapists, for example, where found to be 
significantly more likely to remain in therapy, comply with the prescribed 
medication regimens, and achieve better outcomes with less medication [75]. 
4. Assurance of the selection and implementation of a consumer-desired plan. 
 
Implementing SDM in psychiatric settings presents several difficulties. Fragmented 
services, learned helplessness, prejudice, discrimination and the fear of coercive 
consequences can challenge psychiatric patient’s ability to actively and fully engage in 
shared decision-making [44]. Research shows, however, that those with severe mental 
health illness are able to participate in decision-making [48, 76], and that legal definitions 
of impaired competency to make health decisions affect only a minority of people 
diagnosed with mental disorders namely those with dementia or learning disabilities [2]. 
Among other problems patients commonly mention time restrictions as a barrier against 
SDM behaviors. It takes time to share information and preferences for treatments and to 
negotiate a course of action, as indicated by the finding that greater SDM behaviors are 
associated with longer visit duration [39, 49, 52, 77]. For instance discussion of health 
behaviors using SDM in the negotiation of behavior change is feasible in a 15- to 20-
minute visit [50]. Consultation setting and organizational characteristics was also found 
to influence SDM behaviors. Physicians working in a health maintenance organization 
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practice made fewer attempts to involve patients in the decision process [52], 
constrained by organizational factors such as formularies and treatment guidelines. 
Culturally influenced attitudes and customs may represent facilitators or barriers to 
patient participation. Discrepancies in the ethnic, racial, cultural or social background of 
physicians and patients where described as obstacles to gather information regarding 
preferences and sharing decision-making processes [77].  
Communication skills as the use of language that patients could understand, ability to 
negotiate and provide information were mentioned by physicians as facilitating a more 
co-operative relationship and simplify the decision-making task [39]. 
Shared decision-making is not suitable to all mental health situations. Autonomy of the 
patient should prevail in elective procedures or when treatment decisions are more 
controversial. However, in emergency and life-threatening situations, some authors 
consider that the paternalistic approach may still be desirable [7]. Due to acute and 
severe illness, an individual may be withdrawn from the decision process because of his 
inability to consciously participate. However, following improvement in their health status, 
he may be able to make a choice regarding continuing therapy. This change in ability 
should be accompanied by a change in the decision-making model used, supported by 
the physicians [39]. Even in situations where patient’s decision-making capacity may be 
affected by the pathology, Psychiatric Advance Directives, where the person sets out 
their wishes beforehand, could be used[78]. These documents allow patients with severe 
and chronic mental illnesses to notify their treatment preferences for future crisis or 
relapses and to appoint a surrogate decision-maker for a period of incompetence. A 
recent review of the effects of advance treatment directives for people with severe mental 
illnesses provided little evidence on the benefits of these directives. Their completion 
rates remain very low [79] although well-suited for conveying patients’ preferences 
congruently with patient-centered care. 
 
 
DECISION-MAKING IN PATIENTS WITH DEPRESSION 
 
Van Grieken and coworkers [80] identified several characteristics of psychiatric 
treatment negatively influencing recovery, engagement in treatment and clinical outcome 
in major depressive disorder (MDD): 
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1. Lack of clarity and consensus regarding the nature of the disorder and its 
treatment between patients and clinicians;  
2. Precarious relationship with the clinician; 
3. Unavailability of mental healthcare when needed; 
4. Insufﬁcient involvement of signiﬁcant others. 
 
All these characteristics may impinge shared-decision, which is only recently been 
discussed in depressive care. The extension of shared decision making to the psychiatric 
context and in particular to depression reveals that most patients with depression are 
seeking information about their illness and treatment, and desire a collaborative 
involvement.  
Preferences for involvement vary in different patients and within patients over time. They 
frequently revisit decisions, requiring ongoing decision support [81], especially during 
antidepressant therapy [82]. It is common for the same patient to experience both 
collaborative and paternalistic models in different decisional contexts. Preferences for 
involvement may not always fit the main models of involvement, requiring more flexible 
processes incorporating complex combinations. Older patients are more likely to accept 
a more traditional, dominant role for the physician, and report less confidence in 
discussing treatment options [47]. Less involvement is also experienced by inpatient in 
detoxification and forensic units [83], or whenever more difficult decisions have to be 
performed [84]. On the contrary, younger [83] patients and those with depression [35] 
demonstrate a greater level of interest for an active role in decision-making.  
Patients with depression have frequently limited knowledge on the availability and 
efficacy of psychiatric treatments [85-87] and (moreover) convey to the clinical encounter 
various preconceived treatment preferences [88]. Raue and coworkers suggest that 
acknowledging patient’s a priori treatment preferences may be conceptualized as a pre-
shared decision-making strategy. A fully developed SDM intervention would determine 
the patient’s preferences and also engage him/her in a dialogue about these 
preferences, review patient decision-aid materials, and conclude with a formulation 
satisfactory to both the patient and the clinician [88]. 
Previous experience with a treatment modality was found to be the strongest predictor 
of preference, with some contradictory results [89]. Preference for counseling therapies 
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[71, 86, 90-96] or psychotherapy [62, 89, 97-105] is high, compared to medication. 
Individuals who believe that their depression has more serious consequences on their 
lives and attribute their depression to marital, family or interpersonal problems are prone 
to prefer psychotherapy [101]. Higher education is also related to psychotherapy 
preference. Depressed patients frequently attribute improved well-being to 
psychotherapy [102], but rarely to antidepressant medication, being less likely to believe 
that their underlying problems can be solved with just medication [89]. In clinical settings 
however most patients receive medication, meaning that less than 50% receive the 
therapy they prefer [86, 101].  
On the other side, although a collaborative care model may improve the access to the 
preferred treatment, meeting a patient’s preference appears not to affect symptom 
reduction or remission rates [71, 92, 99, 106].  
The majority of patients report the need for more information in order to improve the 
decision-making process. Concerns about depression treatments including fears about 
the addictive and harmful properties of antidepressants, worries about taking “too many 
pills” and the stigma attached to taking psychotropic medication [62] are mainly 
discussed with the psychiatrist, but other sources of information (other professionals, 
social contacts or media) may be used as decision aids [81, 84]. Patients feel the need 
for basic information about illness and that treatment options [76] drew on existing 
personal knowledge in order to be personally meaningful and accurate [83]. Low 
preferences for information are associated with higher depression scores and increasing 
age [107] with some patients declaring to feel unable to ask the information they need to 
be involved in the decision-making process [83]. Patients with all severity grades of 
depression are highly interested in information, but moderately interested in participating 
in decision-making [87].  
Pharmacotherapy has become the main modality of depression treatment, but its efficacy 
is reduced by low patient adherence and premature discontinuation [108-110]. Low 
adherence is associated with unrealistic expectations [111], lack of treatment efficacy or 
unacceptable adverse effects [101], and discrepancy between symptom relief and cure 
[110]. The selection of the best antidepressant drug is difficult. There is a lack of evidence 
on their comparative effectiveness [112, 113], no perfect drug [114], and clinicians 
struggle to delivery this information meaninfully while dealing with their own preferences 
[115-117]. 
In a study on the physicians perspective of the decision-making process [118], they 
reported to provide a description of the disorder and to mention the potential risks and 
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benefits of medication, without discussing the potential outcomes of therapy. The most 
common topic was about the risks of taking medication, including side effects. The initial 
collaborative approach does not require exhaustive information to the patient, but 
requires a clear communication about [119]:  
 
1. The chosen drug; 
2. Treatment doses and time; 
3. Time needed for the therapeutic response; 
4. Potential side effects and ways to alleviate them; 
5. Expected length of treatment; 
6. General idea of drug mechanism and action. 
 
Patients receiving this kind of information are more educated and have more positive 
initial beliefs about their medication. Consequently they are more likely to maintain follow 
up appointments and refer to be more satisfied with treatment. Aikens and colleagues 
propose specific educational messages to improve adherence during the first month of 
antidepressant therapy [120] taking into account the patient’s beliefs about the disease 
and about medication, and tailoring the physician behavior to his preferences and 
expectations [121].  
Information must be tailored according patient’s age, education and literacy and the 
presence of cognitive impairment inherent to the disorder [88]. Physicians generally 
report to convey information orally and use fact-sheets from public or not-for-profit 
organizations. A recent article [117] reports that the use of depression decision aids 
improves the decision-making process, but no differences were detected in the evolution 
of depressive symptoms, remission rate or responsiveness to treatment. 
Etiologic attributions of depressed patients were found to vary across cultural groups [62, 
104, 122-126], and Vega et al. [127] emphasize the importance of communicating with 
depressed patients in their own language, using a participatory decision-making style 
intrinsic to the patient’s culture, attending to culturally guaranteed expressions of 
depression. These explanatory models may assign milder illness attributions to 
depression and influence help-seeking choices, acceptance to proposed treatments and 
treatment preferences [125, 128].  
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As an example, religion beliefs can influence help-seeking and service utilization [129-
131]. Correlations were found between religious involvement and major depressive 
disorder: lower prevalence among persons who use religious coping (attending religious 
services weekly) and higher prevalence in those who listen to religious radio programs 
[132]. Shared decision making interventions should support complementary and faith-
based approaches as treatment adjuncts when appropriate and help patients articulate 
their beliefs about depression’s etiology, severity and factors [88].  
In primary care, first visits of patients with depressive symptoms showed a low rate of 
SDM behaviors [52]. These behaviors did not vary with the severity of the symptoms, but 
were influenced by the setting, patient-initiated requests for medication and physicians 
age [133]. This is consistent with the finding of lack of patient’s involvement in treatment 
decisions in consultations about depression [53]. In contrast physicians report to employ 
a collaborative approach to the decision-making process, leaving the ultimate decision 
to the patient, unless they were being treated involuntarily [118]. Interestingly physicians 
relayed on their ability to gauge non-verbal cues rather than asking the patients explicitly 
how and if they wanted to be involved in SDM.  
From the physician point of view several reasons were mentioned to abide for a 
collaborative approach to decision making in depression [118]: patient’s involvement 
may be therapeutic itself, facilitates engagement and responsibility. Even though, they 
described several situations where they would not follow this model, possibly including 
caregivers in the decision-making process: 
 
1. Severity of depressive symptoms and the associated decline in functioning;  
2. Perceived risk levels, to self or others; 
3. Perceived/own assumption of client preference of involvement; 
4. Age or developmental stage of the client. 
 
Concerns on decisional capacity are also raised in depression with some authors 
reporting a high use of maladaptive decision-making coping patterns [134] like decision 
avoidance and irrational decisions. An inverse correlation between severity of illness and 
confidence about decision-making was also found and the authors concluded that ‘the 
greater the level of decisional conflict, the lower the level of confidence, the higher the 
level of irrational choice, and the more pessimistic and distorted was information 
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processing’. Other authors on the contrary, found no association between depressive 
symptoms and the level of performance on the decision-making process [135].  
Patients perceived a collaborative approach to decision making when physicians 
considered their opinion, talked with them about different treatment options and then 
mutually agreed on a decision [84]. Generally, according to observational studies, 
physicians tend to focus on the problem definition stage, failing to offer to the patient a 
variety of treatment options [53]. 
In depression it is common to involve more participants than the patient-physician dyad 
in decision-making. Caregivers and other relatives are often present in the consultation, 
particularly in the elderly. They have important supportive roles in line with the desired 
by the patient [83, 118, 136].  
Potential negative outcomes of involving caregivers were cited by physicians, such as 
disagreements, critical or unhelpful comments or difficulties in establishing boundaries 
for clinicians not offering family therapy [118]. Research shows conflicting results 
regarding the influence of the involvement of caregivers in the presence of depressive 
symptoms [136]. Pressure from others may contribute to higher levels of decisional 
conflict. Family dynamics may be mostly powerful among particular ethnic groups [88, 
104]. When disagreements with caregivers arose, physicians were reported to respond 
by involving caregivers earlier in the process, exploring and understanding the 
perspective of the caregiver, or restating the rationale or justification for their position 
[118]. 
It is claimed that SDM may directly alleviate key depressive symptoms, such as 
helplessness and hopelessness, indirectly improving clinical outcomes by increasing 
patient adherence [88]. While some studies show that this involvement has positive 
effects regarding treatment acceptance [86], adherence [137], clinical outcomes [138] 
and satisfaction with treatment [139, 140], others fail to show these benefits [71, 90]. 
When considering uniquely the patient treatment preference component of SDM a 
positive influence has been detected in treatment initiation [99] and adherence, but not 
in clinical outcomes [71, 92, 99, 106, 141, 142]. Patients who enact involvement roles 
consistent with their preferences report greater satisfaction or reduced depression than 
those with mismatches [133]. However, preference strength for assigned treatment, but 
not simply congruence, was associated with better treatment initiation and adherence 
[99]. Congruence of preferences per se with assigned treatment was related with 
treatment initiation, but not adherence. This findings suggest that when preferences lack 
intensity or are similarly intense, the most accessible treatment should be offered first. 
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Alternatively, where patient treatment preferences are particularly strong, that option 
should be offered [99]. 
Reasons for the patient involvement included: engagement process, adherence to 
treatment, safety, autonomy and empowerment [83]. This involvement surpasses 
traditional treatment type decisions, including decisions about location of care and 
employment. Negative aspects of involving patients were also mentioned, such as 
disengagement from treatment, refusal of a treatment option that could offer some 
benefit and overwhelming of the patient when they were unwell [118]. 
Dealing with decision-making in depressive disorders implies considerering specific 
difficulties namely the perception of the disorder including the stigma, the delay in 
seeking help and the absence of information given to patients about depression 
treatment options [84]. These specificities may represent barriers for a shared-decision-
making approach, which may be grouped in four categories [83, 118]:  
 
1. Patient or caregiver related: depressive symptoms, level of risk assigned to 
patient, poor engagement, preconceived perceptions (e.g., perception of 
paternalism and coerciveness), confidentiality, family conflict; 
2. Physician related: lack of communication, breaks in trust, reluctance to disclose 
side-effects, disagreement between professionals, different styles and 
approaches to individual patients, disorganization, underestimation of patient’s 
abilities;  
3. Service related: time constrains, a aprioristic decisions, inpatient settings, 
accessibility; 
4. Broader: stigma, lack of evidence, restriction of funding. 
 
It has been suggested that this barriers can be overcome by explicitly offering 
involvement when making decisions about treatment, and involving the caregivers when 
appropriate [83]. Stigmatization may be avoided by treatment in general practice [91], 
but patients were aware of the limited treatment options available in this setting [84]. For 
older patients, for example, accessibility and stigma can be particularly troublesome, and 
they may be persuaded to use natural herbal remedies rather than evidence-based 
therapies, or misconstrue depressive symptoms as natural consequences of aging or 
medical illness, minimizing the need for treatment [143]. Older adults who met diagnostic 
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criteria for mental disorders were less likely to perceive a need for mental health care, to 
receive specialty mental health care or counseling, or to receive referrals from primary 
care to mental health specialty care than young or middle-aged adults [144-146].  
Time constrains are present in current medical system. Patients request substantially 
more time to communicate with their physician [102]. Time pressure has been 
considered a barrier to SDM; research in primary care settings regarding depression 
treatment found that the longer the consultation time, the higher scores on decision-
sharing behaviors were reported [49]. However, these behaviors, while increasing 
patient participation and satisfaction, did not increased consultations time significantly 
[140].  
Conversely some factors were already identified which contribute to facilitate SDM such 
as: adequate time, culture of the team, treating voluntary clients, having referral options, 
professional culture and a general shift in healthcare culture towards collaborative 
approaches and informed clients [118]. 
 
 
CONCLUSION 
 
The patient-physician relationship is embodied with therapeutic actions. The 
communication between both and with the social network around becomes central to the 
process of cure. In this rich discussion between medical knowledge, its individualization 
to the patient’s reality and the patient values, preferences and needs, there is a tendency 
for the patient to take the frontline.  
Shared-decision appears to be the ideal commitment in the majority of clinical situations, 
even in most psychiatric settings. When dealing with patients with depression, sharing 
technical knowledge and information and the joined participation in the process of 
decision seems to be welcomed, and even desired. The consequent decision model 
promotes feelings of self-value and capacity, aspects withdrawn by the illness and 
valuable to the recovery. 
This idealized collaboration poses new challenges to the physician in developing new 
strategies for interacting and new ways of navigating the relationship with the psychiatric 
patient, focused in understanding, towards a new and better care. In order to use a model 
of shared disease management, there are new habits and skills that need to be learnt. 
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On the patient side, there is a necessity to promote autonomy and empower him with the 
necessary information to exercise it, training his ability to disclose preferences and 
tenets. On the physician side, there is a need to defy the paternalistic approach and help 
the patient to develop self-efficacy and exert more control. This means increased 
demands on the communication ability and deliberation skills of both intervenient. Only 
fulfilling this requirements, the proposed benefits of a shared relationship will become 
real and translate into measurable personal and clinical outcomes.  
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For systematic reviews and meta-analyses consult PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) http://www.prisma-statement.org/
For statistical analysis and reporting, consult SAMPL (Basic Statistical Reporting for Articles Published
in Biomedical Journals: The "Statistical Analyses and Methods in the Published Literature") http://
www.equator-network.org/reporting-guidelines/sampl/
For qualitative studies, see specific editorials published in PEC: Finset A. Qualitative methods in
communication and patient education research. Patient Educ Couns, Volume 73, Issue 1, October
2008, Pages 1-2. DOI: 10.1016/j.pec.2008.08.004
Salmon P. Assessing the quality of qualitative research. Patient Educ Couns Volume 90, Issue 1,
January 2013, Pages 1-3. DOI: 10.1016/j.pec.2012.11.018
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Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for
review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the
Internet)
• Relevant declarations of interest have been made
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
For further information, visit our Support Center.
BEFORE YOU BEGIN
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Human and animal rights
If the work involves the use of human subjects, the author should ensure that the work described has
been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration
of Helsinki) for experiments involving humans; Uniform Requirements for manuscripts submitted to
Biomedical journals. Authors should include a statement in the manuscript that informed consent
was obtained for experimentation with human subjects. The privacy rights of human subjects must
always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in
accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU
Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care
and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should
clearly indicate in the manuscript that such guidelines have been followed.
Policy and Ethics
For work described in your article involving human experimental investigations of any kind, must
have been carried out in accordance with The Code of Ethics of the Declaration of Helsinki; http://
www.wma.net/e/policy/b3.htm
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations
that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/
registrations, and grants or other funding. If there are no conflicts of interest then please state this:
'Conflicts of interest: none'. More information.
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Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis or as an electronic
preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more
information), that it is not under consideration for publication elsewhere, that its publication is
approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or
in any other language, including electronically without the written consent of the copyright-holder. To
verify originality, your article may be checked by the originality detection service CrossCheck.
Contributors
Each author is required to declare his or her individual contribution to the article: all authors must have
materially participated in the research and/or article preparation, so roles for all authors should be
described. The statement that all authors have approved the final article should be true and included
in the disclosure.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and
design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the
article or revising it critically for important intellectual content, (3) final approval of the version to
be submitted.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their
manuscript and provide the definitive list of authors at the time of the original submission. Any
addition, deletion or rearrangement of author names in the authorship list should be made only
before the manuscript has been accepted and only if approved by the journal Editor. To request such
a change, the Editor must receive the following from the corresponding author: (a) the reason
for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they
agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of
authors after the manuscript has been accepted. While the Editor considers the request, publication
of the manuscript will be suspended. If the manuscript has already been published in an online issue,
any requests approved by the Editor will result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see
more information on this). An e-mail will be sent to the corresponding author confirming receipt of
the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version
of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal
circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations. If
excerpts from other copyrighted works are included, the author(s) must obtain written permission
from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for
use by authors in these cases.
For open access articles: Upon acceptance of an article, authors will be asked to complete an
'Exclusive License Agreement' (more information). Permitted third party reuse of open access articles
is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More
information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
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Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or
preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in
the collection, analysis and interpretation of data; in the writing of the report; and in the decision to
submit the article for publication. If the funding source(s) had no such involvement then this should
be stated.
Funding body agreements and policies
Elsevier has established a number of agreements with funding bodies which allow authors to comply
with their funder's open access policies. Some funding bodies will reimburse the author for the Open
Access Publication Fee. Details of existing agreements are available online.
After acceptance, open access papers will be published under a noncommercial license. For authors
requiring a commercial CC BY license, you can apply after your manuscript is accepted for publication.
Open access
This journal offers authors a choice in publishing their research:
Open access
• Articles are freely available to both subscribers and the wider public with permitted reuse.
• An open access publication fee is payable by authors or on their behalf, e.g. by their research funder
or institution.
Subscription
• Articles are made available to subscribers as well as developing countries and patient groups through
our universal access programs.
• No open access publication fee payable by authors.
Regardless of how you choose to publish your article, the journal will apply the same peer review
criteria and acceptance standards.
For open access articles, permitted third party (re)use is defined by the following Creative Commons
user licenses:
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective
work (such as an anthology), as long as they credit the author(s) and provided they do not alter or
modify the article.
The open access publication fee for this journal is USD 3300, excluding taxes. Learn more about
Elsevier's pricing policy: https://www.elsevier.com/openaccesspricing.
Green open access
Authors can share their research in a variety of different ways and Elsevier has a number of
green open access options available. We recommend authors see our green open access page for
further information. Authors can also self-archive their manuscripts immediately and enable public
access from their institution's repository after an embargo period. This is the version that has been
accepted for publication and which typically includes author-incorporated changes suggested during
submission, peer review and in editor-author communications. Embargo period: For subscription
articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers
before an article becomes freely available to the public. This is the embargo period and it begins from
the date the article is formally published online in its final and fully citable form.
This journal has an embargo period of 12 months.
Elsevier Publishing Campus
The Elsevier Publishing Campus (www.publishingcampus.com) is an online platform offering free
lectures, interactive training and professional advice to support you in publishing your research. The
College of Skills training offers modules on how to prepare, write and structure your article and
explains how editors will look at your paper when it is submitted for publication. Use these resources,
and more, to ensure that your submission will be the best that you can make it.
AUTHOR INFORMATION PACK 18 Sep 2016 www.elsevier.com/locate/pec 9
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of
these). Authors who feel their English language manuscript may require editing to eliminate possible
grammatical or spelling errors and to conform to correct scientific English may wish to use the English
Language Editing service available from Elsevier's WebShop.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which
should be documented in the paper. Appropriate consents, permissions and releases must be obtained
where an author wishes to include case details or other personal information or images of patients
and any other individuals in an Elsevier publication. Written consents must be retained by the author
and copies of the consents or evidence that such consents have been obtained must be provided to
Elsevier on request. For more information, please review the Elsevier Policy on the Use of Images or
Personal Information of Patients or other Individuals. Unless you have written permission from the
patient (or, where applicable, the next of kin), the personal details of any patient included in any
part of the article and in any supplementary materials (including all illustrations and videos) must
be removed before submission.
All authors must include one of these two statements at the end of their manuscript:
(1)" I confirm all patient/personal identifiers have been removed or disguised so the patient/person(s)
described are not identifiable and cannot be identified through the details of the story."
OR
(2) " I confirm that the patient/person(s) have read this manuscript and given their permission for
it to be published in PEC".
Submission
Our online submission system guides you stepwise through the process of entering your article
details and uploading your files. The system converts your article files to a single PDF file used in
the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for
final publication. All correspondence, including notification of the Editor's decision and requests for
revision, is sent by e-mail.
Submit your article
Please submit your article via http://ees.elsevier.com/pec/.
PREPARATION
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text
should be in single-column format. Keep the layout of the text as simple as possible. Most formatting
codes will be removed and replaced on processing the article. In particular, do not use the word
processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts,
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.
The electronic text should be prepared in a way very similar to that of conventional manuscripts (see
also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics
will be required whether or not you embed your figures in the text. See also the section on Electronic
artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your word processor.
Article structure
Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered
1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this
numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be
given a brief heading. Each heading should appear on its own separate line.
Manuscripts should be organized as follows:
Title page, Abstract, 1. Introduction, 2. Methods, 3. Results, 4. Discussion and Conclusion,
References, Legends.
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Discussion and Conclusion should be headed as one section and divided into three parts. Example:
4. Discussion and Conclusion, 4.1. Discussion, 4.2. Conclusion. 4.3 Practice Implications
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature
survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be
indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise.
Discussion and Conclusion
Discussion and Conclusion should be headed as one section and divided into three parts. Example:
4. Discussion and Conclusion, 4.1. Discussion, 4.2. Conclusion. 4.3 Practice Implications
Practice Implications
Articles should include a paragraph or paragraphs entitled 'Practice Implications' as part of the
discussion and conclusion, which outlines the implications for practice suggested by the study. Authors
should take care that these implications follow closely from the data presented, rather than from
other literature. In the event that an article presents very preliminary data or conclusions, these
paragraphs may be omitted
Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix,
Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid
abbreviations and formulae where possible.
• Author names and affiliations. Please clearly indicate the given name(s) and family name(s)
of each author and check that all names are accurately spelled. Present the authors' affiliation
addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-
case superscript letter immediately after the author's name and in front of the appropriate address.
Provide the full postal address of each affiliation, including the country name and, if available, the
e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing
and publication, also post-publication. Ensure that the e-mail address is given and that contact
details are kept up to date by the corresponding author.
• Present/permanent address. If an author has moved since the work described in the article was
done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as
a footnote to that author's name. The address at which the author actually did the work must be
retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A structured abstract, by means of appropriate headings, should provide the context or background for
the research and should state its purpose, basic procedures (selection of study subjects, observational
and analytical methods), main findings (giving specific effect sizes and their statistical significance,
if possible), principal conclusions and practice implications. Abstracts should adhere to the following
format: Objective, Methods, Results, Conclusion, Practice Implications. The word limit for
abstracts is 200.
Highlights
Highlights are mandatory for this journal. They consist of a short collection of bullet points that
convey the core findings of the article and should be submitted in a separate editable file in the
online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points
(maximum 85 characters, including spaces, per bullet point). You can view example Highlights on
our information site.
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Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those
individuals who provided help during the research (e.g., providing language help, writing assistance
or proof reading the article, etc.).
Formatting of funding sources
List funding sources in this standard way to facilitate compliance to funder's requirements:
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy];
the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes
of Peace [grant number aaaa].
It is not necessary to include detailed descriptions on the program or type of grants and awards. When
funding is from a block grant or other resources available to a university, college, or other research
institution, submit the name of the institute or organization that provided the funding.
If no funding has been provided for the research, please include the following sentence:
This research did not receive any specific grant from funding agencies in the public, commercial, or
not-for-profit sectors.
Units
Follow internationally accepted rules and conventions: use the international system of units (SI). If
other units are mentioned, please give their equivalent in SI.
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article. Many word
processors can build footnotes into the text, and this feature may be used. Otherwise, please indicate
the position of footnotes in the text and list the footnotes themselves separately at the end of the
article. Do not include footnotes in the Reference list.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or
use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.
A detailed guide on electronic artwork is available.
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then
please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is
finalized, please 'Save as' or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of
500 dpi.
Please do not:
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a
low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
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Color artwork
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF), or
MS Office files) and with the correct resolution. If, together with your accepted article, you submit
usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear
in color online (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations
are reproduced in color in the printed version. For color reproduction in print, you will receive
information regarding the costs from Elsevier after receipt of your accepted article. Please
indicate your preference for color: in print or online only. Further information on the preparation of
electronic artwork.
Illustration services
Elsevier's WebShop offers Illustration Services to authors preparing to submit a manuscript but
concerned about the quality of the images accompanying their article. Elsevier's expert illustrators
can produce scientific, technical and medical-style images, as well as a full range of charts, tables
and graphs. Image 'polishing' is also available, where our illustrators take your image(s) and improve
them to a professional standard. Please visit the website to find out more.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Please submit tables as editable text and not as images. Tables can be placed either next to the
relevant text in the article, or on separate page(s) at the end. Number tables consecutively in
accordance with their appearance in the text and place any table notes below the table body. Be
sparing in the use of tables and ensure that the data presented in them do not duplicate results
described elsewhere in the article. Please avoid using vertical rules.
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice
versa). Any references cited in the abstract must be given in full. Unpublished results and personal
communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the
journal and should include a substitution of the publication date with either 'Unpublished results' or
'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted
for publication.
Reference links
Increased discoverability of research and high quality peer review are ensured by online links to
the sources cited. In order to allow us to create links to abstracting and indexing services, such as
Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please
note that incorrect surnames, journal/book titles, publication year and pagination may prevent link
creation. When copying references, please be careful as they may already contain errors. Use of the
DOI is encouraged.
A DOI can be used to cite and link to electronic articles where an article is in-press and full citation
details are not yet known, but the article is available online. A DOI is guaranteed never to change,
so you can use it as a permanent link to any electronic article. An example of a citation using DOI
for an article not yet in an issue is: VanDecar J.C., Russo R.M., James D.E., Ambeh W.B., Franke M.
(2003). Aseismic continuation of the Lesser Antilles slab beneath northeastern Venezuela. Journal
of Geophysical Research, http://dx.doi.org/10.1029/2001JB000884i. Please note the format of such
citations should be in the same style as all other references in the paper.
Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any
further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a
different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in
the text) to other articles in the same Special Issue.
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Reference management software
Most Elsevier journals have their reference template available in many of the most popular reference
management software products. These include all products that support Citation Style Language
styles, such as Mendeley and Zotero, as well as EndNote. Using the word processor plug-ins from
these products, authors only need to select the appropriate journal template when preparing their
article, after which citations and bibliographies will be automatically formatted in the journal's style.
If no template is yet available for this journal, please follow the format of the sample references and
citations as shown in this Guide.
Users of Mendeley Desktop can easily install the reference style for this journal by clicking the following
link:
http://open.mendeley.com/use-citation-style/patient-education-and-counseling
When preparing your manuscript, you will then be able to select this style using the Mendeley plug-
ins for Microsoft Word or LibreOffice.
Reference style
Text: Indicate references by number(s) in square brackets in line with the text. The actual authors
can be referred to, but the reference number(s) must always be given.
Example: '..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ....'
List: Number the references (numbers in square brackets) in the list in the order in which they appear
in the text.
Examples:
Reference to a journal publication:
[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, The art of writing a scientific article, J. Sci. Commun.
163 (2010) 51–59.
Reference to a book:
[2] W. Strunk Jr., E.B. White, The Elements of Style, fourth ed., Longman, New York, 2000.
Reference to a chapter in an edited book:
[3] G.R. Mettam, L.B. Adams, How to prepare an electronic version of your article, in: B.S. Jones, R.Z.
Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 2009, pp. 281–304.
Reference to a website:
[4] Cancer Research UK, Cancer statistics reports for the UK. http://www.cancerresearchuk.org/
aboutcancer/statistics/cancerstatsreport/, 2003 (accessed 13.03.03).
Reference citations should be numbered consecutively throughout using Arabic numerals in
parentheses or square brackets (not superscripts). References should be double-spaced and start
on a separate page. References should conform to the system used in Uniform Requirements
for Manuscripts Submitted to Biomedical Journals (Brit Med J 1991;302:338-41; N Engl J Med
1991;324:424-8), using standard abbreviations of the journal titles cited in Current Contents.
Note All authors' names should be listed. Issue numbers should not be included.
Video
Elsevier accepts video material and animation sequences to support and enhance your scientific
research. Authors who have video or animation files that they wish to submit with their article are
strongly encouraged to include links to these within the body of the article. This can be done in the
same way as a figure or table by referring to the video or animation content and noting in the body
text where it should be placed. All submitted files should be properly labeled so that they directly
relate to the video file's content. In order to ensure that your video or animation material is directly
usable, please provide the files in one of our recommended file formats with a preferred maximum size
of 150 MB. Video and animation files supplied will be published online in the electronic version of your
article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with your files: you can
choose any frame from the video or animation or make a separate image. These will be used instead
of standard icons and will personalize the link to your video data. For more detailed instructions please
visit our video instruction pages. Note: since video and animation cannot be embedded in the print
version of the journal, please provide text for both the electronic and the print version for the portions
of the article that refer to this content.
Supplementary material
Supplementary material can support and enhance your scientific research. Supplementary files
offer the author additional possibilities to publish supporting applications, high-resolution images,
background datasets, sound clips and more. Please note that such items are published online exactly
as they are submitted; there is no typesetting involved (supplementary data supplied as an Excel
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file or as a PowerPoint slide will appear as such online). Please submit the material together with the
article and supply a concise and descriptive caption for each file. If you wish to make any changes to
supplementary data during any stage of the process, then please make sure to provide an updated
file, and do not annotate any corrections on a previous version. Please also make sure to switch off the
'Track Changes' option in any Microsoft Office files as these will appear in the published supplementary
file(s). For more detailed instructions please visit our artwork instruction pages.
AudioSlides
The journal encourages authors to create an AudioSlides presentation with their published article.
AudioSlides are brief, webinar-style presentations that are shown next to the online article on
ScienceDirect. This gives authors the opportunity to summarize their research in their own words
and to help readers understand what the paper is about. More information and examples are
available. Authors of this journal will automatically receive an invitation e-mail to create an AudioSlides
presentation after acceptance of their paper.
AFTER ACCEPTANCE
Online proof correction
Corresponding authors will receive an e-mail with a link to our online proofing system, allowing
annotation and correction of proofs online. The environment is similar to MS Word: in addition to
editing text, you can also comment on figures/tables and answer questions from the Copy Editor.
Web-based proofing provides a faster and less error-prone process by allowing you to directly type
your corrections, eliminating the potential introduction of errors.
If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions
for proofing will be given in the e-mail we send to authors, including alternative methods to the online
version and PDF.
We will do everything possible to get your article published quickly and accurately. Please use this
proof only for checking the typesetting, editing, completeness and correctness of the text, tables and
figures. Significant changes to the article as accepted for publication will only be considered at this
stage with permission from the Editor. It is important to ensure that all corrections are sent back
to us in one communication. Please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility.
Offprints
The corresponding author will, at no cost, receive a customized Share Link providing 50 days free
access to the final published version of the article on ScienceDirect. The Share Link can be used
for sharing the article via any communication channel, including email and social media. For an
extra charge, paper offprints can be ordered via the offprint order form which is sent once the
article is accepted for publication. Both corresponding and co-authors may order offprints at any
time via Elsevier's Webshop. Corresponding authors who have published their article open access do
not receive a Share Link as their final published version of the article is available open access on
ScienceDirect and can be shared through the article DOI link.
AUTHOR INQUIRIES
Visit the Elsevier Support Center to find the answers you need. Here you will find everything from
Frequently Asked Questions to ways to get in touch.
You can also check the status of your submitted article or find out when your accepted article will
be published.
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